Artivion
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Employees
- 1.5K
- Market Cap
- -
- Introduction
Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. Its products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.
Retrospective Evaluation of Photo-oxidized Decellularized Bovine Pericardium in Cardiac Repair or Reconstruction Surgery
- Conditions
- Congenital Heart DiseaseCardiac Anomaly
- Interventions
- Device: PhotoFix
- First Posted Date
- 2022-04-06
- Last Posted Date
- 2023-01-13
- Lead Sponsor
- Artivion Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT05314868
- Locations
- ๐บ๐ธ
Children's Hospital of Boston, Boston, Massachusetts, United States
PERSEVERE- a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection
- Conditions
- Acute Aortic Dissection
- Interventions
- Device: AMDS
- First Posted Date
- 2022-01-03
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Artivion Inc.
- Target Recruit Count
- 115
- Registration Number
- NCT05174767
- Locations
- ๐บ๐ธ
University of Alabama at Birmingham, Birmingham, Alabama, United States
๐บ๐ธUniversity of Southern California, Los Angeles, California, United States
๐บ๐ธStanford University, Palo Alto, California, United States
PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban
- Conditions
- Aortic Valve DiseaseAortic Valve StenosisAortic Valve Failure
- Interventions
- First Posted Date
- 2019-10-29
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Artivion Inc.
- Target Recruit Count
- 863
- Registration Number
- NCT04142658
- Locations
- ๐บ๐ธ
Stanford University Medical Center, Palo Alto, California, United States
๐บ๐ธPiedmont Atlanta Hospital, Atlanta, Georgia, United States
๐บ๐ธNorthwestern Memorial Hospital, Chicago, Illinois, United States
Post-market, Prospective Evaluation of PHOTO-oxidized Bovine Pericardium in Vascular Surgery
- Conditions
- Peripheral Arterial DiseaseCarotid Artery DiseasesAbdominal Aortic AneurismVascular DiseasesHemodialysis Access Failure (Disorder)
- Interventions
- Device: PhotoFix
- First Posted Date
- 2018-09-13
- Last Posted Date
- 2024-10-07
- Lead Sponsor
- Artivion Inc.
- Target Recruit Count
- 94
- Registration Number
- NCT03669042
- Locations
- ๐บ๐ธ
Iowa Heart Center, Des Moines, Iowa, United States
๐บ๐ธBrigham and Women's Hospital, Boston, Massachusetts, United States
๐บ๐ธUniversity of Michigan, Ann Arbor, Michigan, United States
Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClotยฎ Polysaccharide Hemostatic System
- Conditions
- Blood Loss, Surgical
- Interventions
- Device: PerClot Polysaccharide Hemostatic SystemDevice: Arista AH
- First Posted Date
- 2015-02-10
- Last Posted Date
- 2022-03-17
- Lead Sponsor
- Artivion Inc.
- Target Recruit Count
- 324
- Registration Number
- NCT02359994
- Locations
- ๐บ๐ธ
Indiana University d/b/a/ Methodist Research Institute, Indianapolis, Indiana, United States